20 Late-Breaking Clinical Trials To Be Presented at The VEINS and VIVA 2023
SOURCE: VIVA Foundation

Leading experts are set to unveil findings from 20 clinical trials during the upcoming annual gatherings of VIVA and The VEINS conferences, taking place from Monday, October 30, to Wednesday, November 1, at Wynn Las Vegas.


VIVA, (Vascular InterVentional Advances) prioritizes innovation and cross-disciplinary knowledge exchange. The 2023 event marks VIVA's 21st anniversary, solidifying its position as a premier educational forum for specialists in peripheral vascular diseases.


The VEINS (Venous Endovascular INterventional Strategies) conference offers a comprehensive platform centered on the diagnosis, intervention, and management of venous disorders.


Access the complete schedule for both conferences.





Monday 30th October 2023


1-Year Clinical Outcomes of Deep Vein Thrombosis Patients Treated With Mechanical Thrombectomy: Analysis of the CLOUT Registry – Presented by Dr David Dexter (Clinical Trials: NCT03575364)


Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System: The VIVID Trial – Presented by Dr Mahmood Razavi. (Clinical Trials: NCT04580160)


First-in-Human: Safety and Performance of the Akura Medical Thrombectomy System in Treating Venous Thromboembolism – Presented by Dr Jay Mathews


Local Anti-Inflammation to Augment Deep Vein Thrombosis Intervention: 6-Month Results From the Open-Label Phase of the DEXTERITY-AFP Trial – Presented by Dr David Dexter (Clinical Trials: NCT04862468)





Tuesday 31st October 2023


12-Month Results From the PROMISE II U.S. Pivotal Trial of the LimFlow System – Presented by Dr Daniel Clair (Clinical Trials: NCT03970538)


Wearable, Non-Invasive Therapeutic Ultrasound to Increase Perfusion in Chronic Limb-Threatening Ischemia: An Early Feasibility Study – Presented by Dr Mahmood Razavi


1-Year Results of the DEEPER OUS Trial: The Bare Temporary Spur Stent System in Combination With a Paclitaxel-Coated Balloon – Presented by Dr Thomas Zeller (Clinical Trials: NCT03807531)


Directional vs Orbital Atherectomy of Femoropopliteal Artery Lesions: Revascularization and Restenosis Rates at 24 Months – Presented by Dr Anvar Babaev


5-Year Outcomes of the Gore® Viabahn® Endoprosthesis for the Treatment of Complex Femoropopliteal Lesions in a Japanese Population – Presented by Dr Osamu Iida


Wound Assessment and Outcomes in the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit BTK™ Drug-Eluting Resorbable Scaffold – Presented by Dr Raghu Kolluri (Clinical Trials: NCT04227899)


RESOLV FIH 6-Month Results by Rutherford Classification – Presented by Dr Eric Secemsky


IN.PACT AV Access Trial Thrombosis Predictors – Presented by Dr Robert Lookstein (Clinical Trials: NCT03041467)



Wednesday 01st November



A Multicenter Trial Evaluation of the Neuroguard Carotid Artery Stent System With Integrated Embolic Protection: 30-Day Outcomes of PERFORMANCE II – Presented by Dr William Gray (Clinical Trials: NCT04201132)


Acute Clinical and 90-Day Functional Outcomes in Pulmonary Embolism Patients Treated With Computer-Aided Thrombectomy: Interim Analysis of the STRIKE-PE Study – Presented by Dr Ido Weinberg (Clinical Trials: NCT04798261)


30-Day Results From the C-Guardians Pivotal Trial of the CGuard™ Carotid Stent System – Presented by Dr Christopher Metzger (Clinical Trials: NCT04900844)


Stellarex Vascular E-Registry (SAVER) Gender Subgroup Analysis – Presented by Dr Marianne Brodmann


Clinical Outcomes of Sirolimus-Coated Balloons Compared With Standard Balloon Angioplasty for Patients With Chronic Limb-Threatening Ischemia – Presented by Dr Edward Choke


Final Data From the SAFE-DCB U.S. Real-World Multicenter Registry – Presented by Dr Nicholas Shammas


Compelling 36-Month Outcomes for the BioMimics 3D Stent in TASC-D Lesions: A Subgroup Analysis of the MIMICS-3D EU Registry – Presented by Dr Robert Beasley


Safety and Performance of Percutaneous Transmural Femoropopliteal Bypass With the DETOUR System: Pooled Analysis of DETOUR1 and DETOUR2 Studies – Presented by Dr Sean Lynden (Clinical Trials: NCT03119233)